A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.

【安进减肥药Maritide二阶段首部分临床平均减重20%】6月24日消息，安进的减肥药Maritide在第二阶段第一部分临床研究中成果显著。该药物展现出平均减重20%的良好效果。

The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...

Amgen's experimental obesity drug MariTide showed promising weight loss results with fewer side effects, according to a ...

Trial finds weight loss drug taken monthly helps people lose 20% of body weight - The new drug may rival other weight loss ...